These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26711126)

  • 1. Carbapenem-Resistant Enterobacteriaceae Infections in Children.
    Chiotos K; Han JH; Tamma PD
    Curr Infect Dis Rep; 2016 Jan; 18(1):2. PubMed ID: 26711126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.
    Morrill HJ; Pogue JM; Kaye KS; LaPlante KL
    Open Forum Infect Dis; 2015 Apr; 2(2):ofv050. PubMed ID: 26125030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.
    Hansen GT
    Infect Dis Ther; 2021 Mar; 10(1):75-92. PubMed ID: 33492641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam.
    Wenzler E; Scoble PJ
    Infect Dis Ther; 2020 Dec; 9(4):769-784. PubMed ID: 33025557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis.
    Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T; Okonogi S
    J Infect Public Health; 2024 May; 17(5):727-734. PubMed ID: 38513335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections Caused by Carbapenem-Resistant
    Sheu CC; Chang YT; Lin SY; Chen YH; Hsueh PR
    Front Microbiol; 2019; 10():80. PubMed ID: 30761114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cohort Study of the Impact of Carbapenem-Resistant
    Sabino S; Soares S; Ramos F; Moretti M; Zavascki AP; Rigatto MH
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30971443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.
    Chiotos K; Hayes M; Gerber JS; Tamma PD
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):56-66. PubMed ID: 31872226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-Resistant
    Bologna E; Licari LC; Manfredi C; Ditonno F; Cirillo L; Fusco GM; Abate M; Passaro F; Di Mauro E; Crocetto F; Pandolfo SD; Aveta A; Cilio S; Di Filippo I; Barone B; Franco A; Arcaniolo D; La Rocca R; Pinchera B; Napolitano L
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
    Temkin E; Adler A; Lerner A; Carmeli Y
    Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
    Logan LK; Weinstein RA
    J Infect Dis; 2017 Feb; 215(suppl_1):S28-S36. PubMed ID: 28375512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.
    Smibert O; Satlin MJ; Nellore A; Peleg AY
    Curr Infect Dis Rep; 2019 Jun; 21(7):26. PubMed ID: 31183574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-resistant
    Adesanya OA; Igwe HA
    AIMS Public Health; 2020; 7(4):804-815. PubMed ID: 33294483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global trends and hotspots in research of carbapenem-resistant Enterobacteriaceae (CRE): a bibliometric analysis from 2010 to 2020.
    Zhong H; Chen F; Li YJ; Zhao XY; Zhang ZL; Gu ZC; Yu YT
    Ann Palliat Med; 2021 Jun; 10(6):6079-6091. PubMed ID: 34237952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae.
    Dong LT; Espinoza HV; Espinoza JL
    AIMS Microbiol; 2020; 6(3):176-182. PubMed ID: 33134739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradicating Biofilms of Carbapenem-Resistant Enterobacteriaceae by Simultaneously Dispersing the Biomass and Killing Planktonic Bacteria with PEGylated Branched Polyethyleneimine.
    Heydarian N; Wouters CL; Neel A; Ferrell M; Panlilio H; Haight T; Gu T; Rice CV
    ChemMedChem; 2023 Feb; 18(3):e202200428. PubMed ID: 36542457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.